Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo‐oxygenase products in rat skin allografts

No abstract is available for this paper.

• Publication year

  1984

• Venue

  British Journal of Pharmacology

• Publication date

  1984-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.1984.tb10087.xPMID 6423022PMCID PMC1986882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoregulatory activity of metabolites of arachidonic acid and their role in inflammation.

  1983cited by this paper
• Cyclosporin A--a pre-recruitment action in the cutaneous response?

  1983cited by this paper
• Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production.

  1983cited by this paper
• BLOOD FLOW, HISTAMINE CONTENT AND HISTIDINE DECARBOXYLASE ACTIVITY IN RAT SKIN GRAFTS AND THEIR MODIFICATION BY CYCLOSPORIN‐A

  1982cited by this paper
• Abrogation of suppressor cell function by inhibitors of prostaglandin synthesis.

  1982cited by this paper
• Effects of anti-arthritic drugs on the release of mononuclear cell factors (MCF) that stimulate prostaglandin (PG) E2 production by rheumatoid synovial cells

  1982cited by this paper
• Prostaglandin E inhibits the production of human interleukin 2

  1982cited by this paper
• Synergism of (15 S)-15-methyl-prostaglandin E1 with either azathioprine or prednisolone on the survival of heart allografts in rats.

  1982cited by this paper
• Role of prostaglandin E2 in the induction of nonspecific T lymphocyte suppressor activity.

  1981cited by this paper
• Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2

  1981cited by this paper
• Anti-PGE antibodies inhibit in vivo development of cell-mediated immunity

  1981cited by this paper
• Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses.

  1981cited by this paper
• Cyclic nucleotides in immunosuppression--neuroendocrine pharmacologic manipulation and in vivo immunoregulation of immunity acting via second messenger systems.

  1980cited by this paper
• Cyclic nucleotides in immunosuppression--neuroendocrine pharmacologic manipulation and in vivo immunoregulation of immunity acting via second messenger systems.

  1980cited by this paper
• A new approach to anti-inflammatory drugs.

  1979cited by this paper
• Prostaglandins and macrophages.

  1979cited by this paper
• Prostaglandins and macrophages.

  1979cited by this paper
• CHANGES IN BLOOD FLOW AND MEDIATOR CONTENT OF RABBIT SKIN GRAFTS

  1978cited by this paper
• Prolongation of murine skin allografts by prostaglandin E1.

  1977cited by this paper
• Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell

  1977cited by this paper
• Degradation of porstaglandin F2alpha in the human pulmonary circulation.

  1976cited by this paper
• Control of lymphokine secretion by prostaglandins

  1976cited by this paper
• Circulating prostaglandin E and allograft rejection.

  1975cited by this paper
• Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.

  1974cited by this paper
• The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes.

  1972cited by this paper
• Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin.

  1971cited by this paper
• Degradation of prostaglandin F 2 a in the human pulmonary circulation

  year unknowncited by this paper

• Pharmacological neuroprotective therapy for acute spinal cord injury: state of the art.

  2008cites this paper
• Protective effect of cyclosporin-A in spinal cord injury: an overview.

  2006cites this paper
• Pharmacologic manipulation of a four day murine delayed type hypersensitivity model

  2005cites this paper
• Inhibition of Lipid Peroxidation by Cyclosporin After Spinal Cord Injury in Rats

  2003cites this paper
• Stimulation of angiogenesis by substance P and interleukin‐1 in the rat and its inhibition by NK1 or interleukin‐1 receptor antagonists

  1993cites this paper
• Effects of cyclosporin A on the blood flow of the native and transplanted rat pancreas and duodenum

  1993cites this paper
• Cyclosporin A-Induced Embryopathy in Embryo Culture Is Mediated through Inhibition of the Arachidonic Acid Pathway

  1993cites this paper
• The evaluation of pharmacologic agents on composite graft survival.

  1992cites this paper
• Biological actions and pathophysiologic significance of endothelin in the kidney.

  1991cites this paper
• Anti-allergic properties of cyclosporin A: inhibition of mediator release from human basophils and rat basophilic leukemia cells (RBL-2H3).

  1990cites this paper
• Ciclosporin A inhibits endothelium-dependent vasodilatation and vascular prostacyclin production.

  1989cites this paper
• Pharmacology of cyclosporine. VI. Cellular activation: regulation of intracellular events by cyclosporine.

  1989cites this paper
• An increase in the ratio of thromboxane A2 to prostacyclin in association with increased blood pressure in patients on cyclosporine A.

  1989cites this paper
• CYCLOSPORINE‐INDUCED HYPOTENSION

  1989cites this paper
• The effect of cyclosporine alone and with steroids on arachidonic acid metabolites.

  1988cites this paper
• PROTECTION AGAINST CYCLOSPORINE‐INDUCED IMPAIRMENT OF RENAL MICROCIRCULATION BY VERAPAMIL IN MICE

  1988cites this paper
• Vasodilatory prostaglandins and cyclosporin nephrotoxicity.

  1988cites this paper
• EXPERIMENTAL TRANSPLANTATION AND CYCLOSPORINE

  1988cites this paper
• Hypothyroidism after treatment with ketoconazole.

  1987cites this paper
• Glomerular hemodynamics and hormonal participation on cyclosporine nephrotoxicity.

  1987cites this paper
• EVIDENCE THAT RENAL PROSTAGLANDIN AND THROMBOXANE PRODUCTION IS STIMULATED IN CHRONIC CYCLOSPORINE NEPHROTOXICITY

  1987cites this paper
• Alfacalcidol and hypercalcaemia.

  1987cites this paper
• Endoscopic removal of a pharmacobezoar of slow release theophylline.

  1987cites this paper
• Fluorouracil and angina.

  1987cites this paper
• MECHANISM OF ACTION OF CYCLOSPORINE IN PREVENTING CARDIAC ALLOGRAFT REJECTION: II. Graft Tissue Levels of Prostacyclin and Thromboxane

  1987cites this paper
• Cyclosporine: Chemistry, Structure-Activity Relationships and Mode of Action

  1986cites this paper
• Arachidonic acid metabolism in human neutrophils: lack of effect of cyclosporine A.

  1986cites this paper
• Experimental transplantation.

  1986cites this paper
• Endoscopic removal of pharmacobezoar of slow release theophylline.

  1986cites this paper
• Release of eicosanoids from cultured rat aortic endothelial cells; studies with arachidonic acid and calcium ionophore A23187.

  1986cites this paper
• Release of eicosamoids from cultured rat aortic endothelial cells; studies with arachidonic acid and calcium ionophore A23187

  1986cites this paper
• Mechanism of cyclosporin A-induced inhibition of prostacyclin synthesis by macrophages.

  1985cites this paper
• The problems associated with conversion from azathioprine and prednisolone to cyclosporine.

  1985cites this paper
• Effects of cyclosporin A on fetal development in the rat.

  1985cites this paper
• Cyclosporine nephrotoxicity: studies in laboratory animals.

  1985cites this paper
• Cyclosporin A--a pre-recruitment action in the cutaneous response?

  1983cites this paper